PULLUP ENTERTAINMENT PULLUP ENTERTAINMENT : Record Q3 2024/25 revenue of €100.8 million. 16-Jan-2025 / 17:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is ...

organic Medjool date palms at Oasis Date's Corn Springs Ranch in California.

6 February 22 at 07:45 (CET). A press and analyst conference will be held on the ...

million new shares in the Company, raising gross proceeds of NOK 35 million (the “Rights Issue”) and listing of up to 60 million new shares in the Company in a private placement directed towards the ...

SD: Standard Deviation. Imputed data in alignment with the statistical analysis plan. Figures in this table were extracted from eTable 2 of the article. The RESTORE sample consists of the RESCUE and ...

transported 1.2 million cbm of cargo on prorated basis. Transported cargo in the last three months (October – December) was 3.5 million cbm. Average prorated gross freight rate in December 2024 was ...

preliminary CABU and CLEANBU TCE earnings for Q4 2024 ended at $/day 28,988 and $/day 28,027, respectively. Fleet average TCE earnings for the quarter ended at $/day 28,527 approximately $/day 1,700 ...

available closer to the event date on varenergi.no/en/investor. Vår Energi will also publish its fourth quarter and full year 2024 results at 07:00 CET on the same ...

Shares") at a fixed price of EUR 0.45 per Offer Share (the "Offer Price"), to raise gross proceeds to the Company of EUR 14 million (the "Offer Size").

Exploration and Reservoir Development in Aker BP. Aker BP is offered licenses in the North Sea and the Norwegian Sea. West of Yggdrasil, Aker BP is offered operatorship on the former Frigg field, ...

its employee share purchase program related to 2022. Participants in the share purchase program are eligible to receive one bonus share for every one share bought in 2022, given these shares have not ...

Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. Transgene’s programs utilize viral vector technology with ...